Our data demonstrated that Wee1 participated in promoting cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1. Here, ATM is linked to chronic myelogenous leukemia, BCR-ABL1 positive.